PI3K/Akt/mTOR-IN-2
PI3K/Akt/mTOR-IN-2 is a PI3K/AKT/mTOR pathway inhibitor. PI3K/Akt/mTOR-IN-2 possess anti-cancer effects and selectivity against MDA-MB-231 cells with IC50 value of 2.29 μM. PI3K/Akt/mTOR-IN-2 can induce cancer cell cycle arrest and apoptosis[1].
Product Specifications
CAS Number
[2757804-89-8]
UNSPSC
12352005
Target
Akt; Apoptosis; mTOR; PI3K
Type
Reference compound
Related Pathways
Apoptosis; PI3K/Akt/mTOR
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/pi3k-akt-mtor-in-2.html
Purity
99.93
Solubility
DMSO : ≥ 100 mg/mL
Smiles
FC1=CC(F)=CC(C2OCCC3=C2NC4=C3C=CC=C4)=C1
Molecular Formula
C17H13F2NO
Molecular Weight
285.29
References & Citations
[1]Qin J, Sun X, Ma Y, et al. Design, synthesis and biological evaluation of novel 1,3,4,9-tetrahydropyrano[3,4-b]indoles as potential treatment of triple negative breast cancer by suppressing PI3K/AKT/mTOR pathway [published online ahead of print, 2021 Dec 31]. Bioorg Med Chem. 2021;55:116594.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Goat Polyclonal Goat anti-Mouse IgG F(ab) Secondary Antibody [DyLight 350]](https://cdn.genprice.uk/genprice/uk/genprice3.webp)
NBP2-68470UV 1 mL
Goat Polyclonal Goat anti-Mouse IgG F(ab) Secondary Antibody [DyLight 350]
Ask
View Details 
MBS4380317-01 0.02 mg (With BSA & Azide at 0.2mg/mL)
CD9 (TSPAN29) (Motility-Related Protein-1)
Ask
View Details MBS4380317-02 0.1 mg (With BSA & Azide at 0.2mg/mL)
CD9 (TSPAN29) (Motility-Related Protein-1)
Ask
View Details MBS4380317-03 0.1 mg (Without BSA & Azide at 1mg/mL)
CD9 (TSPAN29) (Motility-Related Protein-1)
Ask
View Details